Last 14.00 GBp
Change Today +0.25 / 1.82%
Volume 4.0K
ODX On Other Exchanges
Symbol
Exchange
London
As of 3:44 AM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

omega diagnostics group plc (ODX) Snapshot

Open
14.00 GBp
Previous Close
13.75 GBp
Day High
14.00 GBp
Day Low
14.00 GBp
52 Week High
02/25/14 - 35.13 GBp
52 Week Low
11/26/13 - 13.75 GBp
Market Cap
15.2M
Average Volume 10 Days
41.8K
EPS TTM
0.0060 GBp
Shares Outstanding
108.7M
EX-Date
--
P/E TM
23.3x
Dividend
--
Dividend Yield
--
Current Stock Chart for OMEGA DIAGNOSTICS GROUP PLC (ODX)

Related News

No related news articles were found.

omega diagnostics group plc (ODX) Related Businessweek News

No Related Businessweek News Found

omega diagnostics group plc (ODX) Details

Omega Diagnostics Group PLC, together with its subsidiaries, manufactures, develops, and distributes medical diagnostics products. The company operates in three segments: Allergy and Autoimmune, Food Intolerance, and Infectious Diseases. The Allergy and Autoimmune segment researches, develops, produces, and markets in vitro allergy and autoimmune tests that are used by doctors to diagnose patients with allergies and autoimmune diseases. This segment’s principal products include Allergozyme, Allergodip, and Genesis Elisa. The Food Intolerance segment engages in the research, development, and production of kits to aid the detection of immune reactions to food. This segment also provides clinical analysis to the general public, clinics, and health professionals, as well as supplies consumer food detective test products. Its principal products include Genarrayt microarray, Food Detective, and Foodprint service. The Infectious Diseases segment is involved in the research, development, production, and marketing of kits that are used in the diagnosis of infectious diseases. Its principal products comprise Immutrep Syphilis, Micropath Bacterial tests, and Dengue Elisa. The company offers its products to hospitals, blood banks, clinics, and laboratories through distributors and sales teams in approximately 100 countries worldwide. Omega Diagnostics Group PLC was founded in 1987 and is headquartered in Alva, the United Kingdom.

135 Employees
Last Reported Date: 07/11/14
Founded in 1987

omega diagnostics group plc (ODX) Top Compensated Officers

Founder, Managing Director, Chief Executive O...
Total Annual Compensation: 145.0K GBP
Group Finance Director, Company Secretary and...
Total Annual Compensation: 115.0K GBP
Group Sales & Marketing Director and Executiv...
Total Annual Compensation: 110.0K GBP
Compensation as of Fiscal Year 2014.

omega diagnostics group plc (ODX) Key Developments

Omega Diagnostics Group plc Announces Trading Update for the First Half Ended September 30, 2014; Revised Earnings Guidance for the Full Year 2014

Omega Diagnostics Group PLC announced trading update for the first half ended September 30, 2014. Turnover is expected to be £5.69 million, slightly ahead of last year's first-half result of £5.59 million. Due to careful management of costs and an improved segmental mix of business, profit before tax (before acquisition costs, share based payments, IFRS-related discount unwinds and amortisation of intangible assets) is expected to be approximately £0.56 million, some 30% ahead of the £0.43 million earned in the previous half-year period to 30 September 2013. The management of the company expects that 2014 financial performance will be below that previously envisaged.

Omega Diagnostics Group PLC Announces Consolidated Financial Results for the Year Ended March 31, 2014

Omega Diagnostics Group PLC announced consolidated financial results for the year ended March 31, 2014. For the year, the company reported revenue of £11,593,870 against £11,262,898 a year ago. Operating profit was £527,325 against £306,645 a year ago. Profit before taxation was £543,041 against £276,224 a year ago. Profit for the year was £692,851 or 0.7 pence per diluted share against £582,266 or 0.7 pence per diluted share a year ago. Adjusted profit before taxation was £1,095,911 against £778,562 a year ago. Adjusted EPS on profit for the year was 1.2 pence against 1.3 pence a year ago. Cash flow from operating activities was £1,669,107 against £1,014,953 a year ago. Purchase of property, plant and equipment was £478,968 against £308,876 a year ago. Purchase of intangible assets was £1,880,845 against £1,185,133 a year ago.

Omega Diagnostics Group PLC, Annual General Meeting, Aug 28, 2014

Omega Diagnostics Group PLC, Annual General Meeting, Aug 28, 2014., at 11:00 GMT Standard Time. Location: Omega House, Hillfoots Business Village.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ODX:LN 14.00 GBp +0.25

ODX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ODX.
View Industry Companies
 

Industry Analysis

ODX

Industry Average

Valuation ODX Industry Range
Price/Earnings 19.7x
Price/Sales 1.3x
Price/Book 0.8x
Price/Cash Flow 20.3x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OMEGA DIAGNOSTICS GROUP PLC, please visit www.omegadiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.